Integra Lifesciences Holdings Corp (IART): Capital Expenditures

Annual figures by period end, from SEC filings.

Restated years: each year's figure is from the latest filing that reports it. The company later restated the year ended 2013-12-31 (for example after a spin-off or a discontinued operation), while the year before it was last reported on the old basis. Changes across those points are marked n/c (not comparable), and growth rates are not computed across them.

$81.44M
Year ended 2025-12-31
$59.52M
Trailing 12 months to 2026-06-30
+24.4%
3-year compound annual growth
+15.9%
5-year compound annual growth
+9.3%
10-year compound annual growth
$104.42M2008-12-31: $13.40M2009-12-31: $25.24M2010-12-31: $37.14M2011-12-31: $38.42M2012-12-31: $69.03M2013-12-31: $42.30M2014-12-31: $38.34M2015-12-31: $33.41M2016-12-31: $47.33M2017-12-31: $43.50M2018-12-31: $77.74M2019-12-31: $69.54M2020-12-31: $38.89M2021-12-31: $48.02M2022-12-31: $42.34M2023-12-31: $66.86M2024-12-31: $104.42M2025-12-31: $81.44M$81.44M
2008-12-31 Capital Expenditures (USD) 2025-12-31
Period endedCapital ExpendituresChange YoYSource filing
2025-12-31$81.44M-22.0%2026-02-26, From 2025-01-01
2024-12-31$104.42M+56.2%2026-02-26, From 2024-01-01
2023-12-31$66.86M+57.9%2026-02-26, From 2023-01-01
2022-12-31$42.34M-11.8%2025-02-25, From 2022-01-01
2021-12-31$48.02M+23.5%2024-02-28, From 2021-01-01
2020-12-31$38.89M-44.1%2023-02-22, From 2020-01-01
2019-12-31$69.54M-10.6%2022-02-24, From 2019-01-01
2018-12-31$77.74M+78.7%2021-02-23, From 2018-01-01
2017-12-31$43.50M-8.1%2020-02-21, From 2017-01-01
2016-12-31$47.33M+41.6%2019-02-26, From 2016-01-01
2015-12-31$33.41M-12.9%2018-03-01, From 2015-01-01
2014-12-31$38.34M-9.4%2017-02-23, From 2014-01-01
2013-12-31$42.30Mn/c2016-02-26, From 2013-01-01
2012-12-31$69.03M+79.7%2015-02-27, From 2012-01-01
2011-12-31$38.42M+3.5%2014-02-27, From 2011-01-01
2010-12-31$37.14M+47.2%2013-02-26, From 2010-01-01
2009-12-31$25.24M+88.3%2012-02-27, From 2009-01-01
2008-12-31$13.40Mn/a2011-02-24, From 2008-01-01

Capital Expenditures at similar companies

Companies with the same SEC industry code (Surgical & Medical Instruments & Apparatus), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedCapital ExpendituresChange YoY
Integra Lifesciences Holdings Corp (IART)2025-12-31$81.44M-22.0%
Merit Medical Systems Inc (MMSI)2025-12-31$81.72M+132.5%
Penumbra Inc (PEN)2025-12-31$63.73M+200.9%
Teleflex Inc (TFX)2025-12-31$95.24M+5.3%
Haemonetics Corp (HAE)2026-03-28$32.78M-16.5%
ICU Medical Inc (ICUI)2025-12-31$88.04M+10.9%
Embecta Corp. (EMBC)2025-09-30$9.30M-41.1%
Tandem Diabetes Care Inc (TNDM)2025-12-31$19.95M+3.7%
Insulet Corp (PODD)2025-12-31$191.60M+53.4%

Compare IART, MMSI, PEN, TFX side by side · Screen every company in Surgical & Medical Instruments & Apparatus ↗